According to the new market research “Electrophoresis Market by Product (Gel Electrophoresis (Horizontal & Vertical) (Agarose & Polyacrylamide), Capillary Electrophoresis, Reagents, Geldoc, Imaging), Application (Diagnostic, Reasearch, Quality Control), End User – Global Forecast to 2022″, analyzes and studies the major market drivers, restraints/challenges, and opportunities. The electrophoresis market is expected to reach USD 2.80 Billion by 2022 from an estimated USD 2.15 Billion in 2017, at a CAGR of 5.4%.
The global Electrophoresis market is segmented based on product, application and end user.
On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. Over the years, genomic and proteomic technologies have gained significant importance in fields of clinical diagnosis and drug discovery and development. These are some of the key factors driving the growth of the electrophoresis market, and in turn supporting the growth of the electrophoresis reagents market during the forecast period.
Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434
Browse and in-depth TOC on in “Electrophoresis Market “
204 – Tables
46 – Figures
244 – Pages
Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.
Request Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=434
Geographically, the global electrophoresis market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2016, North America held the largest share of this market, and this is primarily attributed to the growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes; stringent regulatory requirements regarding pharmaceutical manufacturing necessitating quality control and process validation processes; rising focus on the development of structure-based drug designs; and growing research activities in the fields of Genomics and proteomics.
Market Players
The key players in the Electrophoresis market are Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).
View Complete Press Release @
https://www.marketsandmarkets.com/PressReleases/electrophoresis.asp
New Technologies Transforming the Industrial Business Electrophoresis Market added by Redaktion on
View all posts by Redaktion →